Skip to main content
Top
Published in: AIDS and Behavior 6/2012

01-08-2012 | Original Paper

Reliability of the Lay Adherence Counsellor Administered Substance Abuse and Mental Illness Symptoms Screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a Primary care HIV Clinic in Cape Town, South Africa

Authors: Erica Breuer, Kevin Stoloff, Landon Myer, Soraya Seedat, Dan J. Stein, John Joska

Published in: AIDS and Behavior | Issue 6/2012

Login to get access

Abstract

HIV infection is associated with an increased prevalence of common mental disorders and with the development of HIV associated neurological disorders (HAND). The aim of this research was to determine the reliability of lay adherence counsellors in the administration of the substance abuse and mental illness symptom screener (SAMISS) for common mental disorders and International HIV Dementia Scale (IHDS) for HAND in a South African sample of 269 people living with HIV/AIDS and on HAART in a primary healthcare setting. We used a cross-sectional design with each patient assessed by a mental health nurse and counsellor, 1 week apart. Reliability was fair for the SAMISS overall (κ = 0.39, CI95 0.29–0.49, P < 0.01), but was higher for the substance abuse component compared to the mental illness component. Reliability for the IHDS between counsellors and nurses was slight (κ = 0.11, CI95 0.00–0.27, P < 0.02). Counsellors tended not to miss symptoms, and detected symptoms more often than nurses for the both the SAMISS and IHDS. Strategies to improve the ability of primary healthcare providers to screen for neurocognitive disorders as well as avoiding over-detection of mental illness and substance abuse symptoms need to be developed and implemented for the primary healthcare setting.
Literature
1.
go back to reference Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.PubMedCrossRef Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.PubMedCrossRef
2.
go back to reference Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.PubMedCrossRef Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.PubMedCrossRef
3.
go back to reference Fairfield KM, Libman H, Davis RB, Eisenberg DM. Delays in protease inhibitor use in clinical practice. J Gen Intern Med. 1999;14(7):395–401.PubMedCrossRef Fairfield KM, Libman H, Davis RB, Eisenberg DM. Delays in protease inhibitor use in clinical practice. J Gen Intern Med. 1999;14(7):395–401.PubMedCrossRef
4.
go back to reference Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. J Am Med Assoc. 2001;285(11):1466–74.CrossRef Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. J Am Med Assoc. 2001;285(11):1466–74.CrossRef
5.
go back to reference Ironson G, Balbin E, Stuetzle R, Fletcher MA, O’Cleirigh C, Laurenceau JP, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Intern J Behav Med. 2005;12(2):86–97.CrossRef Ironson G, Balbin E, Stuetzle R, Fletcher MA, O’Cleirigh C, Laurenceau JP, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Intern J Behav Med. 2005;12(2):86–97.CrossRef
6.
go back to reference Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123–7.PubMed Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123–7.PubMed
7.
go back to reference Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci. 2009;9(Suppl 1):S2–7.PubMed Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci. 2009;9(Suppl 1):S2–7.PubMed
8.
go back to reference Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.PubMedCrossRef Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.PubMedCrossRef
9.
go back to reference Lucas M, Stevenson D. Violence and abuse in psychiatric in-patient institutions: a South African perspective. Int J Law Psychiatry. 2006;29(3):195–203.PubMedCrossRef Lucas M, Stevenson D. Violence and abuse in psychiatric in-patient institutions: a South African perspective. Int J Law Psychiatry. 2006;29(3):195–203.PubMedCrossRef
10.
go back to reference Kalichman SC, Simbayi LC, Kagee A, Toefy Y, Jooste S, Cain D, et al. Associations of poverty, substance use, and HIV transmission risk behaviors in three South African communities. Soc Sci Med. 2006;62(7):1641–9.PubMedCrossRef Kalichman SC, Simbayi LC, Kagee A, Toefy Y, Jooste S, Cain D, et al. Associations of poverty, substance use, and HIV transmission risk behaviors in three South African communities. Soc Sci Med. 2006;62(7):1641–9.PubMedCrossRef
11.
go back to reference Simbayi LC, Kalichman SC, Jooste S, Mathirti V, Cain D, Cherry C. Alcohol use and sexual risks for HIV infection among men and women receiving sexually transmitted infection clinic services in Cape Town, South Africa. J Stud Alcohol. 2004;65(4):434–42.PubMed Simbayi LC, Kalichman SC, Jooste S, Mathirti V, Cain D, Cherry C. Alcohol use and sexual risks for HIV infection among men and women receiving sexually transmitted infection clinic services in Cape Town, South Africa. J Stud Alcohol. 2004;65(4):434–42.PubMed
12.
go back to reference Kalichman SC, Simbayi LC, Cain D, Jooste S. Alcohol expectancies and risky drinking among men and women at high-risk for HIV infection in Cape Town South Africa. Addict Behav. 2007;32(10):2304–10.PubMedCrossRef Kalichman SC, Simbayi LC, Cain D, Jooste S. Alcohol expectancies and risky drinking among men and women at high-risk for HIV infection in Cape Town South Africa. Addict Behav. 2007;32(10):2304–10.PubMedCrossRef
13.
go back to reference Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134–40.PubMedCrossRef Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134–40.PubMedCrossRef
14.
go back to reference Elliott AJ, Russo J, Roy-Byrne PP. The effect of changes in depression on health related quality of life (HRQoL) in HIV infection. Gen Hosp Psychiatry. 2002;24(1):43–7.PubMedCrossRef Elliott AJ, Russo J, Roy-Byrne PP. The effect of changes in depression on health related quality of life (HRQoL) in HIV infection. Gen Hosp Psychiatry. 2002;24(1):43–7.PubMedCrossRef
15.
go back to reference Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 2002;136(10):765–776. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 2002;136(10):765–776.
16.
go back to reference Patel V, Araya R, Chowdhary N, King M, Kirkwood B, Nayak S, et al. Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires. Psychol Med. 2008;38(2):221–8.PubMedCrossRef Patel V, Araya R, Chowdhary N, King M, Kirkwood B, Nayak S, et al. Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires. Psychol Med. 2008;38(2):221–8.PubMedCrossRef
17.
go back to reference Whetten K, Reif S, Swartz M, Stevens R, Ostermann J, Hanisch L, et al. A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care STDS. 2005;19(2):89–99.PubMedCrossRef Whetten K, Reif S, Swartz M, Stevens R, Ostermann J, Hanisch L, et al. A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care STDS. 2005;19(2):89–99.PubMedCrossRef
18.
go back to reference Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr. 2005;40(4):434–44.PubMedCrossRef Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr. 2005;40(4):434–44.PubMedCrossRef
19.
go back to reference Sacktor NC, Wong M, Nakasujjac N, Skolaskya RS, Selnesa OA, Musisic S, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.PubMed Sacktor NC, Wong M, Nakasujjac N, Skolaskya RS, Selnesa OA, Musisic S, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.PubMed
20.
go back to reference Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, et al. Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS. 2011;25(2):95–101.PubMedCrossRef Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, et al. Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS. 2011;25(2):95–101.PubMedCrossRef
21.
go back to reference Sim J, Wright CC. The κ statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–68.PubMed Sim J, Wright CC. The κ statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–68.PubMed
22.
go back to reference Statcorp. STATA. 10 ed. College Station: Statcorp; 2007. Statcorp. STATA. 10 ed. College Station: Statcorp; 2007.
23.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.PubMedCrossRef Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.PubMedCrossRef
24.
go back to reference Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2011;15(6):1197–203.PubMedCrossRef Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2011;15(6):1197–203.PubMedCrossRef
25.
go back to reference Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–50.PubMed Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–50.PubMed
26.
go back to reference Freeman MH, Nkomo N, Kafaar Z, Kelly K. Mental disorder in people living with HIV/AIDS in South Africa. S Afr J Psychol. 2008;38(3):489–500. Freeman MH, Nkomo N, Kafaar Z, Kelly K. Mental disorder in people living with HIV/AIDS in South Africa. S Afr J Psychol. 2008;38(3):489–500.
27.
go back to reference Myer L, Smit J, Le Roux L, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care and STDs. 2008;22(2):147–58.PubMedCrossRef Myer L, Smit J, Le Roux L, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care and STDs. 2008;22(2):147–58.PubMedCrossRef
28.
go back to reference Olley BO, Gxamza F, Seedat S, Theron H, Taljaard J, Reid E, et al. Psychopathology and coping in recently diagnosed HIV. S Afr Med J. 2003;93(12):928–31.PubMed Olley BO, Gxamza F, Seedat S, Theron H, Taljaard J, Reid E, et al. Psychopathology and coping in recently diagnosed HIV. S Afr Med J. 2003;93(12):928–31.PubMed
29.
go back to reference Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 2010;13:15. Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 2010;13:15.
Metadata
Title
Reliability of the Lay Adherence Counsellor Administered Substance Abuse and Mental Illness Symptoms Screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a Primary care HIV Clinic in Cape Town, South Africa
Authors
Erica Breuer
Kevin Stoloff
Landon Myer
Soraya Seedat
Dan J. Stein
John Joska
Publication date
01-08-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0067-z

Other articles of this Issue 6/2012

AIDS and Behavior 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine